` 239 (Pak Fah Yeow International Ltd) vs Hang Seng (Hong Kong) Comparison - Alpha Spread

239
vs
H
Hang Seng (Hong Kong)

Over the past 12 months, Pak Fah Yeow International Ltd has underperformed Hang Seng (Hong Kong), delivering a return of -2% compared to the Hang Seng (Hong Kong)'s +17% growth.

Stocks Performance
239 vs Hang Seng (Hong Kong)

Loading
239
Hang Seng (Hong Kong)
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
239 vs Hang Seng (Hong Kong)

Performance Gap Between 239 and HSI
HIDDEN
Show

Performance By Year
239 vs Hang Seng (Hong Kong)

Loading
239
Hang Seng (Hong Kong)
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Pak Fah Yeow International Ltd vs Peers

Hang Seng (Hong Kong)
239
JEF
JNJ
4312
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Pak Fah Yeow International Ltd
Glance View

Market Cap
747.9m HKD
Industry
Pharmaceuticals

Pak Fah Yeow International Ltd. is an investment holding company, which engages in the manufacture and sale of healthcare products under the brand name of Hoe Hin. The firm operates through three segments. Healthcare segment is engaged in the manufacture and sales of Hoe Hin products. Property Investment segment is engaged in the investment in commercial, industrial and residential properties. Treasury Investment segment is engaged in treasury investment. The firm mainly operates businesses in Hong Kong, China, Britain and Singapore, among others.

Pak Fah Yeow International Ltd Intrinsic Value
HIDDEN
Show
Back to Top